The majority of animal models for dominant ARS1 diseases have focused on GlyRS and TyrRS variants, however, results from these studies provide a valuable starting point for investigating the pathophysiology underlying neuropathies caused by mutations in the other ARS1 genes. This evidence concerns the gene YARS2 and neuropathy.